TABLE 3.
Drug resistance mutation prevalence
| Drug class | Mutation | No. of specimensa | % of specimens |
|---|---|---|---|
| NRTI | Any | 91 | 88.3 |
| M41L | 35 | 34.0 | |
| K65R | 8 | 7.8 | |
| D67G | 5 | 4.9 | |
| D67N | 26 | 25.2 | |
| T69N | 10 | 9.7 | |
| K70R | 26 | 25.2 | |
| L74I | 6 | 5.8 | |
| V75I | 6 | 5.8 | |
| V75M | 8 | 7.8 | |
| Y115F | 6 | 5.8 | |
| M184V | 88 | 85.4 | |
| L210W | 25 | 24.3 | |
| T215F | 20 | 19.4 | |
| T215Y | 25 | 24.3 | |
| K219E | 8 | 7.8 | |
| K219Q | 18 | 17.5 | |
| NNRTI | Any | 90 | 87.4 |
| A98G | 17 | 16.5 | |
| K101E | 9 | 8.7 | |
| K103N | 43 | 41.7 | |
| V108I | 11 | 10.7 | |
| Y181C | 21 | 20.4 | |
| Y188L | 5 | 4.9 | |
| G190A | 29 | 28.2 | |
| H221Y | 11 | 10.7 | |
| PI | Any majorb | 5 | 4.9 |
NRTI and NNRTI mutations detected in at least 5 plasma specimens are shown.
PI mutations observed: M46I (n = 2), G48M (1), I50V (1), I54V (3), V82A (3), V82L (1), L90M (3).